常德腰痛结石(常德结石诗句) (今日更新中)

WASHINGTON, May 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Sutent to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body.Neuroendocrine tumors found in the pancreas are slow-growing and rare. It is estimated that there are fewer than 1,000 new cases in the United States each year.This is the second new approval by the FDA to treat patients with this disease. On May 5, the agency approved Afinitor."FDA believes it is important to provide cancer patients with as many treatment options as possible," said Richard Pazdur, director of the Office of Oncology Drug Products in the FDA's Center for Drug Evaluation and Research. "The agency is committed to working with companies to bring innovative new therapies to the market and encourages companies to continue exploring additional uses for approved products."The safety and effectiveness of Sutent was established in a single study of 171 patients with metastatic (late-stage) or locally advanced (disease that could not be removed with surgery) disease who received Sutent or a placebo (sugar pill). The study was designed to measure the length of time a patient lived before their disease spread or worsened (progression-free survival).Results from the study demonstrate that Sutent provided benefit to patients by prolonging the median length of time they lived without the cancer spreading or worsening to 10.2 months compared to 5.4 months for patients who received placebo.In patients treated with Sutent for neuroendocrine pancreatic tumors, the most commonly reported side effects included diarrhea, nausea, vomiting, fatigue, anorexia, high blood pressure, energy loss, stomach pain, changes in hair color, inflammation of the mouth, and a decrease in infection-fighting white blood cells.Sutent is marketed by New York City-based Pfizer.

BEIJING, Feb. 21 (Xinhua) -- China's domestic air travelers, as well as international passengers in and out of China, will be the biggest boost to airline industry growth over the next four years, according to an industry outlook report by the International Air Transport Association (IATA) Monday.Of the world's expected 800 million new travelers by 2014, about 181 million new passengers will come from China's domestic air routes, while another 33 million will be passengers flying to or from China via international routes, IATA said.China's 181 million domestic air passengers growth will lift the country's domestic passenger throughput to 379 million by 2014, only behind the United States in the world's aviation traveler volume ranking, according to IATA.The United States will remain the largest single country market for domestic passengers, with 671 million domestic air travelers and international passengers by then, according to IATA's forecast.The world's air travelers will top 3.3 billion by 2014, up by 800 million from the 2.5 billion in 2009, while world air cargo will rise to 38 million tonnes from 26 million tonnes in 2009."The forecast indicates that the world will continue to become more mobile. This creates enormous opportunities but also presents some challenges," Giovanni Bisignani, IATA' s Director General and CEO, said in the outlook report."We will need even more efficient air traffic management, airport facilities and security programs," he said, adding the shadow of the global economic recession is expected to remain over parts of the industry for some time to come.He said lingering consumer debt, high unemployment and austerity measures will dampen growth rates in Europe and North America, shifting the industry's focus eastwards.By 2014, 1 billion people will travel by air in the Asia-Pacific region, accounting for 30 percent of the global total, up from 26 percent in 2009, he added.

LOS ANGELES, May 6 (Xinhua) -- Limiting prolonged bottle use in children may be an effective way to help prevent obesity, a new study suggests.For the study, researchers from the Center for Obesity Research and Education at Temple University (CORETU) and the Ohio State University College of Public Health analyzed data from 6,750 children to estimate the association between bottle use at 24 months of age and the risk of obesity at 5.5 years of age, according to the Science Daily on Friday.Of the children studied, 22 percent were prolonged bottle users, meaning that at two years of age they used a bottle as their primary drink container and/or were put to bed with a calorie- containing bottle.The findings showed that nearly 23 percent of the prolonged bottle users were obese by the time they were 5.5 years old."Children who were still using a bottle at 24 months were approximately 30 percent more likely to be obese at 5.5 years, even after accounting for other factors such as the mother's weight, the child's birth weight, and feeding practices during infancy," said Dr. Robert Whitaker at CORETU, lead author of the study.Drinking from a bottle beyond infancy may contribute to obesity by encouraging the child to consume too many calories, the researchers noted."A 24-month-old girl of average weight and height who is put to bed with an eight-ounce bottle of whole milk would receive approximately 12 percent of her daily caloric needs from that bottle," explained co-author Rachel Gooze.Gooze noted that weaning children from the bottle by the time they are one year of age is unlikely to cause harm and may prevent obesity. The authors suggested that pediatricians and other health professionals work with parents to find acceptable solutions for stopping bottle use at the child's first birthday.The findings adds new evidence to the theory that obesity prevention should begin before children enter school, the researchers said.

SYDNEY, May 24 (Xinhua) -- Australian soldiers and contractors in Iraq might have been exposed to blood-borne diseases such as HIV or hepatitis, as staff at Defense's main hospital unit in the Middle East failed to sterilize surgical equipment properly, local media reported on Tuesday.Fairfax newspapers reported the safety breach occurred at the AL Minhad Air Base in the United Arab Emirates over a 19 month period, from February 2009 to August 2010, but soldiers were alerted to the problem only a week ago.A Defense Department memo to troops has warned that soldiers and contractors who passed through the air base hospital near Dubai should ensure they had their blood screened, The Sydney Morning Herald reported."Personnel who underwent a surgical procedure during that period are possibly at risk of acquiring a blood-borne disease," the memo said.However, the health alert says the risk to Australian Defense Force personnel is low, as blood-borne diseases within the force are rare and personnel are vaccinated against hepatitis.The Defense Force's Surgeon-General, Major General Paul Alexander, wrote the "internal procedural issue" was dealt with by the health system and measures were put in place to prevent a repeat of the error.

来源：资阳报